María Patricia Hernández-Mitre , Susan C. Morpeth , Balasubramanian Venkatesh , Thomas E. Hills , Joshua Davis , Robert K. Mahar , Grace McPhee , Mark Jones , James Totterdell , Steven Y.C. Tong , Jason A. Roberts
{"title":"用于治疗成人 COVID-19 的 TMPRSS2 抑制剂:萘伐司他和甲磺酸卡莫司他随机临床试验的系统回顾和荟萃分析》的勘误[《临床微生物学与感染》30 (2024) 743-754]。","authors":"María Patricia Hernández-Mitre , Susan C. Morpeth , Balasubramanian Venkatesh , Thomas E. Hills , Joshua Davis , Robert K. Mahar , Grace McPhee , Mark Jones , James Totterdell , Steven Y.C. Tong , Jason A. Roberts","doi":"10.1016/j.cmi.2024.08.005","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":"31 1","pages":"Page 141"},"PeriodicalIF":10.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Erratum to ‘TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate’ [Clin Microbiol Infect (30) (2024) 743–754]\",\"authors\":\"María Patricia Hernández-Mitre , Susan C. Morpeth , Balasubramanian Venkatesh , Thomas E. Hills , Joshua Davis , Robert K. Mahar , Grace McPhee , Mark Jones , James Totterdell , Steven Y.C. Tong , Jason A. Roberts\",\"doi\":\"10.1016/j.cmi.2024.08.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10444,\"journal\":{\"name\":\"Clinical Microbiology and Infection\",\"volume\":\"31 1\",\"pages\":\"Page 141\"},\"PeriodicalIF\":10.9000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Microbiology and Infection\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1198743X24003859\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1198743X24003859","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Erratum to ‘TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate’ [Clin Microbiol Infect (30) (2024) 743–754]
期刊介绍:
Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.